Literature DB >> 20138444

Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.

Wei Wang1, Haihua Yang, Wei Hu, Guoping Shan, Weijun Ding, Changhui Yu, Biyun Wang, Xufeng Wang, Qianyi Xu.   

Abstract

PURPOSE: To quantify the target and normal structures on dose distributing variations during intensity-modulated radiotherapy (IMRT) and to assess the value of replanning for nasopharyngeal carcinoma (NPC) patients. METHODS AND MATERIALS: Twenty-eight NPC patients treated with IMRT were recruited. The IMRT was delivered in 33 fractions, to 70 to 76Gy, to the gross tumor volume (GTV). Before the 25th fraction of IMRT, a new simulation computed tomography (CT) scan was acquired for all patients. According to the dose constraint criterion in the Radiation Therapy Oncology Group (RTOG) 0225 protocol, the replanning was generated on the new simulation CT. With the Quality Assessment Center of a CORVUS 6.3 treatment planning system, a phantom plan was generated for each patient by applying the beam configurations of the initial plan to the anatomy of the new simulation CT. The dose-volume histograms of the phantom plan were compared with the replanning.
RESULTS: The percentage of prescription dose delivered to the clinical target volume (CTV1) was significantly increased by 4.91% +/- 10.89%, whereas the maximum dose to the spinal cord, mean dose to the left parotid, and V30 to the right parotid were significantly decreased by 5.00 +/- 9.23Gy, 4.23 +/- 10.03Gy, and 11.47% +/- 18.89% respectively in the replanning, compared with the phantom plan (p < 0.05). Based on the dose constraint criterion in the RTOG0225 protocol, 50% of phantom plans (14/28) were out of limit for the dose to the normal critical structures, whereas no plan was out of limit in replanning (p < 0.001).
CONCLUSION: Replanning for patients with NPC before the 25th fraction during IMRT helps to ensure adequate dose to the target volumes and safe doses to critical normal structures. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20138444     DOI: 10.1016/j.ijrobp.2009.08.036

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  46 in total

1.  Is it necessary to repeat CT imaging and replanning during the course of intensity-modulated radiation therapy for locoregionally advanced nasopharyngeal carcinoma?

Authors:  Chuanben Chen; Xiang Lin; Jianji Pan; Zhaodong Fei; Lisha Chen; Penggang Bai
Journal:  Jpn J Radiol       Date:  2013-06-09       Impact factor: 2.374

2.  Strategies to optimize radiotherapy based on biological responses of tumor and normal tissue.

Authors:  Weidong Wang; Jinyi Lang
Journal:  Exp Ther Med       Date:  2012-05-30       Impact factor: 2.447

3.  Practically acquired and modified cone-beam computed tomography images for accurate dose calculation in head and neck cancer.

Authors:  Chih-Chung Hu; Wen-Tao Huang; Chiao-Ling Tsai; Jian-Kuen Wu; Hsiao-Ling Chao; Guo-Ming Huang; Chun-Wei Wang; Chien-Jang Wu; Jason Chia-Hsien Cheng
Journal:  Strahlenther Onkol       Date:  2011-09-23       Impact factor: 3.621

4.  Phase I study of icotinib, an EGFR tyrosine kinase inhibitor combined with IMRT in nasopharyngeal carcinoma.

Authors:  Wei Hu; Wei Wang; Peinong Yang; Chao Zhou; Weifang Yang; Bo Wu; Hongsheng Lu; Haihua Yang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.

Authors:  Y Luo; Y Qin; J Lang
Journal:  Clin Transl Oncol       Date:  2016-10-07       Impact factor: 3.405

6.  The tumor shape changes of nasopharyngeal cancer during chemoradiotherapy: the estimated margin to cover the geometrical variation.

Authors:  Wenyong Tan; Jianzeng Ye; Ruilian Xu; Xianming Li; Wan He; Xiaohong Wang; Yanping Li; Desheng Hu
Journal:  Quant Imaging Med Surg       Date:  2016-04

7.  Anatomic and dosimetric changes in patients with head and neck cancer treated with an integrated MRI-tri-60Co teletherapy device.

Authors:  Govind Raghavan; Amar U Kishan; Minsong Cao; Allen M Chen
Journal:  Br J Radiol       Date:  2016-09-21       Impact factor: 3.039

8.  Adaptive radiation therapy for cervical esophageal cancer: dosimetric and volumetric analysis.

Authors:  Sibel Karaca; Meltem Kırlı
Journal:  J Gastrointest Oncol       Date:  2019-06

9.  Intensity-Modulated Proton Therapy Adaptive Planning for Patients with Oropharyngeal Cancer.

Authors:  Richard Y Wu; Amy Y Liu; Terence T Sio; Pierre Blanchard; Cody Wages; Mayankkumar V Amin; Gary B Gunn; Uwe Titt; Rong Ye; Kazumichi Suzuki; Michael T Gillin; Xiaorong R Zhu; Radhe Mohan; Steven J Frank
Journal:  Int J Part Ther       Date:  2017-12-28

10.  Dosimetric impact on changes in target volumes during intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Authors:  Wafa Mnejja; Hend Daoud; Nejla Fourati; Tarek Sahnoun; Wicem Siala; Leila Farhat; Jamel Daoud
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.